Opinion
Unloved healthcare stocks can reinvent themselves
Those betting on the demise of blue-chip healthcare stocks like CSL and ResMed might want to rethink based on a review of Microsoft and Apple’s histories.
Jun Bei LiuContributorThe healthcare sector has become one of the most discussed topics in the sharemarket due to a severe sell-off. Once a highly coveted sector and a cornerstone of many Australian investment managers’ portfolios, it’s now being shunned like a structurally challenged cyclical business.
Since January, the sector has experienced a 14 per cent decline, while the broader market has been flat over the same period. This makes it the poorest performing sector, even underperforming listed property.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles